Clinical trial SN201
A multicentric phase 1/2 trial to evaluate the safety and efficacy of SOT102 as monotherapy and in combination with standard of care treatment in patients with gastric and pancreatic adenocarcinoma (Sotio - SN201)
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial open for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1/2 |
Academic trial | Non |
Sponsor | Sotio |
EudraCT Identifier | 2021-005873-25 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05525286 |
Last update |